Alteplase is a recombinant human tissue-type plasminogen activator, which activates plasminogen directly to plasmin leading to the dissolution of the fibrin clot.
Pharmaceutical Class: Thrombolytics
Dosage Form and Strength: Lyophilized powder (50 mg) with Sterile water for injection
Product Description:
Indications:
Thrombolytic treatment in acute myocardial infraction (AMI) for the reduction of mortality and reduction of the incidence of heart failure
Thrombolytic treatment in acute massive pulmonary embolism (PE)
Thrombolytic treatment in acute ischemic stroke
ALTELYSE® is the first biosimilar form of Alteplase in the world